EUVIMEDEUVIMED entdecken
Crossref

Synergistic Effects of Activatable Photodynamic Therapy and Crisaborole for Psoriasis through Senolysis and Immunomodulation

Yangxin Yu iD, Xinhang Lv, Zhuowei Chen, Xiaokang Li, Liru Chen, Youyou Chen, Wenhui Gu, Xiantao Zhou, Jian Li iD, Donglei Shi iD

Journal of Medicinal Chemistry · 14.08.2025 · 68 (15) · 16395-16409

DOI: 10.1021/acs.jmedchem.5c01266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 25.07.2025. Verfasst von Yangxin Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, Sc…. Hauptthemen laut MEDLINE: Psoriasis, Photochemotherapy, Boron Compounds, Photosensitizing Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China, Shanghai Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a multifactorial inflammatory disorder characterized by therapeutic resistance and high recurrence rates, with complex unmet clinical demands necessitating novel therapeutic strategies. Recently, emerging evidence has revealed pathological accumulation of senescent cells (SnCs) in psoriatic lesions, suggesting their critical involvement in disease persistence and relapse. Our previous studies demonstrated that precision photodynamic therapy (PDT) effectively eliminates SnCs and mitigates senescence-associated pathologies, positioning senotherapy as a potential breakthrough for psoriasis management. Building on these foundations, we developed SnC-targeted photosensitizers (H2O2-activated TZ0953 and β-gal-activated TZ0993) and revealed that SnC-targeted PDT significantly alleviates psoriatic pathology in psoriasis model mice. Further optimization led to a combination strategy employing TZ0953 with crisaborole, implementing dual-pathway intervention of the clearance of SnCs and inflammatory microenvironment modulation. This “dual-target” approach demonstrated superior efficacy compared to monotherapies. Our work pioneers a “dual-target/modal” strategy and addresses both cellular senescence and inflammatory cascades in psoriasis, providing a novel strategic direction for psoriasis treatment optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisPhotochemotherapyBoron CompoundsPhotosensitizing AgentsCellular SenescenceBridged Bicyclo Compounds, HeterocyclicImmunomodulationAnimalsMiceHumansDrug Synergism

Substanzen

Boron CompoundsPhotosensitizing AgentsBridged Bicyclo Compounds, Heterocycliccrisaborole

Autor:innen und Institutionen

  • Key Laboratory of Tropical Biological Resources of Ministry of Education and Hainan Engineering Research Center for Drug Screening and Evaluation, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, Hai…
  • State Key Laboratory of Bioreactor Engineering, Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Key Laboratory…
  • Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832003, P. R. China.

ORCID-Profile: Yangxin Yu, Jian Li, Donglei Shi

Förderung

  • Innovative Research Team of High-level Local University in Shanghai
  • National Natural Science Foundation of China
  • Shanghai Municipal Education Commission
  • Natural Science Foundation of Hainan Province
  • State Key Laboratory of Bioreactor Engineering
  • Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism

Zitieren

APA

Yu, Y., Lv, X., Chen, Z., Li, X., Chen, L., Chen, Y., Gu, W., Zhou, X., Li, J., & Shi, D. (2025). Synergistic Effects of Activatable Photodynamic Therapy and Crisaborole for Psoriasis through Senolysis and Immunomodulation. Journal of Medicinal Chemistry, 68(15), 16395-16409. https://doi.org/10.1021/acs.jmedchem.5c01266

Vancouver

Yu Y, Lv X, Chen Z, Li X, Chen L, Chen Y, et al. Synergistic Effects of Activatable Photodynamic Therapy and Crisaborole for Psoriasis through Senolysis and Immunomodulation. Journal of Medicinal Chemistry. 2025;68(15):16395-16409. doi:10.1021/acs.jmedchem.5c01266

BibTeX
@article{Yu2025,
  author = {Yu, Yangxin and Lv, Xinhang and Chen, Zhuowei and Li, Xiaokang and Chen, Liru and Chen, Youyou and Gu, Wenhui and Zhou, Xiantao and Li, Jian and Shi, Donglei},
  title = {Synergistic Effects of Activatable Photodynamic Therapy and Crisaborole for Psoriasis through Senolysis and Immunomodulation},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {15},
  pages = {16395--16409},
  doi = {10.1021/acs.jmedchem.5c01266}
}
Kostenlos starten →